These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31137622)

  • 41. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine.
    Song Y; Ding Y; Dong CM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1742. PubMed ID: 34310063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics.
    Hatakeyama H
    Chem Pharm Bull (Tokyo); 2017; 65(7):612-617. PubMed ID: 28674332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces.
    Mi G; Shi D; Wang M; Webster TJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1800103. PubMed ID: 29790304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, challenge, and promise of stimuli-responsive nanoantibiotics.
    Edson JA; Kwon YJ
    Nano Converg; 2016; 3(1):26. PubMed ID: 28191436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulus-responsive targeted nanomicelles for effective cancer therapy.
    Muthu MS; Rajesh CV; Mishra A; Singh S
    Nanomedicine (Lond); 2009 Aug; 4(6):657-67. PubMed ID: 19663594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.
    Subramaniam S; Joyce P; Thomas N; Prestidge CA
    Adv Drug Deliv Rev; 2021 Oct; 177():113948. PubMed ID: 34464665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual stimuli-responsive metal-organic framework-based nanosystem for synergistic photothermal/pharmacological antibacterial therapy.
    Xiao Y; Xu M; Lv N; Cheng C; Huang P; Li J; Hu Y; Sun M
    Acta Biomater; 2021 Mar; 122():291-305. PubMed ID: 33359766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection microenvironment-related antibacterial nanotherapeutic strategies.
    Wang Z; Liu X; Duan Y; Huang Y
    Biomaterials; 2022 Jan; 280():121249. PubMed ID: 34801252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of antibiotics with polymeric particles.
    Xiong MH; Bao Y; Yang XZ; Zhu YH; Wang J
    Adv Drug Deliv Rev; 2014 Nov; 78():63-76. PubMed ID: 24548540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
    Da Costa D; Exbrayat-Héritier C; Rambaud B; Megy S; Terreux R; Verrier B; Primard C
    J Nanobiotechnology; 2021 Jan; 19(1):12. PubMed ID: 33413448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enzyme-Responsive Mesoporous Ruthenium for Combined Chemo-Photothermal Therapy of Drug-Resistant Bacteria.
    Liu Y; Lin A; Liu J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26590-26606. PubMed ID: 31264823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacteria-responsive biopolymer-coated nanoparticles for biofilm penetration and eradication.
    Wang Y; Shukla A
    Biomater Sci; 2022 May; 10(11):2831-2843. PubMed ID: 35441624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.